Preeclampsia Predictor sFlt-1/PIGF Ratio Panel Test
Understanding Preeclampsia and Its Early Detection
Preeclampsia is a serious pregnancy complication that affects approximately 5-8% of pregnancies worldwide. This condition typically develops after 20 weeks of gestation and is characterized by high blood pressure and signs of damage to other organ systems, most often the liver and kidneys. The Preeclampsia Predictor sFlt-1/PIGF Ratio Panel Test represents a significant advancement in prenatal care, offering expectant mothers and healthcare providers a powerful tool for early risk assessment and proactive management.
What Does This Test Measure?
This comprehensive panel evaluates three critical biomarkers that provide essential insights into placental health and function:
- PLGF (Placental Growth Factor): A protein produced by the placenta that promotes the formation of new blood vessels, essential for proper placental development and function
- sFlt-1 (Soluble fms-like tyrosine kinase-1): An anti-angiogenic factor that can inhibit blood vessel formation when present in elevated levels
- PIGF Ratio: The critical ratio between sFlt-1 and PIGF that provides the most accurate assessment of preeclampsia risk
The Science Behind the Test
The test utilizes advanced ECLIA (Electrochemiluminescence Immunoassay) methodology, which offers exceptional sensitivity and specificity in detecting these crucial biomarkers. In normal pregnancies, the balance between pro-angiogenic factors (like PIGF) and anti-angiogenic factors (like sFlt-1) maintains healthy placental function. When this balance is disrupted, with sFlt-1 levels rising and PIGF levels falling, it indicates increased risk for developing preeclampsia.
Who Should Consider This Test?
This test is particularly valuable for pregnant women experiencing or at risk for:
- New-onset hypertension during pregnancy
- Persistent headaches that don’t respond to usual treatments
- Visual disturbances including blurred vision, light sensitivity, or temporary vision loss
- Upper abdominal pain, typically under the ribs on the right side
- Nausea or vomiting developing in the second or third trimester
- Sudden weight gain and swelling (edema) in face and hands
- Shortness of breath
High-Risk Factors
Women with the following risk factors should strongly consider this test:
- First pregnancy
- Previous history of preeclampsia
- Family history of preeclampsia
- Multiple gestation (twins, triplets)
- Maternal age over 40
- Pre-existing conditions like hypertension, diabetes, or kidney disease
- Obesity (BMI over 30)
Benefits of Early Preeclampsia Detection
Taking the Preeclampsia Predictor Test offers numerous advantages for maternal and fetal health:
- Early Intervention: Allows for timely medical management and monitoring
- Reduced Complications: Helps prevent severe outcomes like eclampsia, HELLP syndrome, and placental abruption
- Informed Decision Making: Provides crucial information for birth planning and timing
- Peace of Mind: Reduces anxiety through proactive monitoring
- Improved Outcomes: Contributes to better health outcomes for both mother and baby
Understanding Your Test Results
Your test results will provide valuable information about your preeclampsia risk:
- Low Ratio: A sFlt-1/PIGF ratio below the established cutoff suggests low short-term risk for preeclampsia
- Elevated Ratio: A ratio above the cutoff indicates increased risk and warrants closer monitoring
- Significantly Elevated Ratio: Very high ratios strongly suggest developing or imminent preeclampsia requiring immediate medical attention
It’s important to discuss your results with your healthcare provider, who will interpret them in the context of your overall clinical picture, symptoms, and medical history. The test results serve as a valuable tool for your obstetrician or gynecologist to make informed decisions about your pregnancy care.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | Preeclampsia Predictor sFlt-1/PIGF Ratio Panel Test |
| Regular Price | $200 USD |
| Discount Price | $112 USD |
| Sample Type | 2 mL (1 mL minimum) serum from 1 SST |
| Sample Collection | Tuesday, Thursday, or Saturday by 9 AM |
| Turnaround Time | Same day results |
| Methodology | ECLIA (Electrochemiluminescence Immunoassay) |
| Preparation | No special preparation required |
Convenient Nationwide Access
We have branches conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art facilities ensure consistent, high-quality testing and rapid result delivery regardless of location.
Take Control of Your Pregnancy Health Today
Don’t wait to get the crucial information you need for a healthy pregnancy. The Preeclampsia Predictor sFlt-1/PIGF Ratio Panel Test provides the advanced screening necessary for proactive pregnancy management. Early detection can make a significant difference in pregnancy outcomes.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our knowledgeable staff is available to answer your questions and help you take the next step toward comprehensive prenatal care.
Invest in your health and your baby’s wellbeing with this advanced diagnostic tool. With same-day results and convenient locations nationwide, getting the information you need has never been easier.
